Cosmo Pharmaceuticals N.V. is a pharmaceutical company specializing in the development and commercialization of innovative products for gastroenterology, dermatology, and health technology worldwide. ... Cosmo Pharmaceuticals N.V. is a pharmaceutical company specializing in the development and commercialization of innovative products for gastroenterology, dermatology, and health technology worldwide. Its portfolio includes GI Genius, an AI-powered computer-assisted system for real-time detection of colorectal lesions during colonoscopies; Winlevi, a topical prescription treatment for acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet for inducing remission in mild to moderate ulcerative colitis; and Uceris/Cortiment, an oral budesonide formulation targeting the colon. Additional offerings encompass Eleview for safer gastrointestinal lesion excision, Lumeblue for enhanced lesion visualization, Aemcolo/Relafalk for travelers' diarrhea, and Byfavo, an intravenous sedative. The company advances a robust pipeline, including Breezula in Phase III trials as a scalp androgen receptor inhibitor for hair loss, Rifamycin enema in Phase II for ulcerative colitis, and early-stage candidates like Colesevelam for bile acid diarrhea and Cortexolone derivatives for solid tumors. Headquartered in Dublin, Ireland, and founded in 1997, Cosmo Pharmaceuticals N.V. partners globally with entities like Medtronic and Bausch Health to distribute its specialized therapies, playing a key role in addressing unmet needs in digestive health, skin conditions, and endoscopic diagnostics.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Cosmo Pharmaceuticals is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Cosmo Pharmaceuticals is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Cosmo Pharmaceuticals's data?

Start your 30-day free trial to request a data review for Cosmo Pharmaceuticals.

Start Free Trial

Legal Center Contact Us